agilon health, inc. (NYSE:AGL) Receives Average Recommendation of “Hold” from Analysts

agilon health, inc. (NYSE:AGL) has been given an average recommendation of “Hold” by the twenty-one ratings firms that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating on the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is $7.81.

AGL has been the subject of a number of analyst reports. Benchmark reiterated a “buy” rating and set a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft decreased their price objective on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a report on Friday, August 9th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Evercore ISI cut their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 8th. Finally, Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research report on Wednesday, October 2nd.

Insider Activity at agilon health

In other news, CEO Steven Sell acquired 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 3.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of AGL. Intech Investment Management LLC purchased a new stake in agilon health during the 3rd quarter worth about $228,000. Simplify Asset Management Inc. lifted its holdings in shares of agilon health by 67.5% in the third quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company’s stock worth $663,000 after buying an additional 67,968 shares in the last quarter. Aigen Investment Management LP bought a new position in shares of agilon health in the third quarter valued at approximately $79,000. Los Angeles Capital Management LLC purchased a new position in agilon health during the third quarter valued at approximately $513,000. Finally, City State Bank bought a new stake in agilon health during the 3rd quarter worth approximately $52,000.

agilon health Stock Performance

NYSE AGL opened at $1.84 on Tuesday. The company has a market cap of $757.12 million, a P/E ratio of -2.52 and a beta of 0.60. The company has a fifty day simple moving average of $3.26 and a 200 day simple moving average of $4.97. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. agilon health has a 12-month low of $1.80 and a 12-month high of $13.76.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.